Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays

Bibliographic Details
Main Author: Ribeiro, Ana R.
Publication Date: 2011
Other Authors: Castro, Paula M.L., Afonso, Carlos, Tiritan, Maria E.
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.14/13239
Summary: Chiral pharmaceuticals and the fate and effects of their enantiomers in the environment are still largely unknown [1, 2]. Enantiomers have different interactions with enzymes, receptors and any chiral molecules leading to different biological activities and affecting organisms in a different manner. Thus, biodegradation tends to be enantioselective in contrast to abiotic degradation. The methods developed to quantify the enantiomeric fraction in the environment and to follow biodegradation are scarce [3]. Thus in this work we describe the development and validation of HPLC methods that allow the enantiomeric separation of widely used drugs namely four beta-blockers: alprenolol (ALP), propranolol (PHO), metoprolol (MET) and atenolol (ATE) and the antidepressant fluoxetine (FX). The macrocyclic antibiotic vancomycin CSP (ASTEC Chirobiotic V 5µm) was used under polar organic mode (methanol:ethanol:triethylamine:acetic acid.50:50 v/v) and fluorescence detection for enantiomeric fraction quantification. The developed methods were established using a minimal medium inoculated with activated sludge as a matrix which is the condition used in the biodegradation studies. The vancomycin CSP was able to resolve ALP and PHO as well as MET, ATE and FX in two chromatographic runs. The chromatographic parameters obtained have shown the separation factor (α) between 1.12 and 1.34 and resolution (Rs) between 1.30 and 4.35. The methods demonstrated to be selective and linearity with r2 higher than 0,999 for the range selected. The method detection limits were between 2.5 to 10ng/mL. These methods were applied to follow the biodegradation of the target chiral compounds during 15 days. The biodegradation assays were performed using activated sludge from a WWTP and the results indicate the higher degradation extents for the S- enantiomer forms.
id RCAP_bfb87b205d211047d60c3650d4ba0c1d
oai_identifier_str oai:repositorio.ucp.pt:10400.14/13239
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assaysbiodegradationchiralpharmaceuticalsChiral pharmaceuticals and the fate and effects of their enantiomers in the environment are still largely unknown [1, 2]. Enantiomers have different interactions with enzymes, receptors and any chiral molecules leading to different biological activities and affecting organisms in a different manner. Thus, biodegradation tends to be enantioselective in contrast to abiotic degradation. The methods developed to quantify the enantiomeric fraction in the environment and to follow biodegradation are scarce [3]. Thus in this work we describe the development and validation of HPLC methods that allow the enantiomeric separation of widely used drugs namely four beta-blockers: alprenolol (ALP), propranolol (PHO), metoprolol (MET) and atenolol (ATE) and the antidepressant fluoxetine (FX). The macrocyclic antibiotic vancomycin CSP (ASTEC Chirobiotic V 5µm) was used under polar organic mode (methanol:ethanol:triethylamine:acetic acid.50:50 v/v) and fluorescence detection for enantiomeric fraction quantification. The developed methods were established using a minimal medium inoculated with activated sludge as a matrix which is the condition used in the biodegradation studies. The vancomycin CSP was able to resolve ALP and PHO as well as MET, ATE and FX in two chromatographic runs. The chromatographic parameters obtained have shown the separation factor (α) between 1.12 and 1.34 and resolution (Rs) between 1.30 and 4.35. The methods demonstrated to be selective and linearity with r2 higher than 0,999 for the range selected. The method detection limits were between 2.5 to 10ng/mL. These methods were applied to follow the biodegradation of the target chiral compounds during 15 days. The biodegradation assays were performed using activated sludge from a WWTP and the results indicate the higher degradation extents for the S- enantiomer forms.VeritatiRibeiro, Ana R.Castro, Paula M.L.Afonso, CarlosTiritan, Maria E.2013-11-14T16:20:17Z20112011-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.14/13239enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-13T16:43:39Zoai:repositorio.ucp.pt:10400.14/13239Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T02:22:33.111196Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
title Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
spellingShingle Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
Ribeiro, Ana R.
biodegradation
chiral
pharmaceuticals
title_short Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
title_full Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
title_fullStr Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
title_full_unstemmed Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
title_sort Chiral HPLC-FD method validation for determination of several Beta-Blockers and Fluoxetine in biodegradation assays
author Ribeiro, Ana R.
author_facet Ribeiro, Ana R.
Castro, Paula M.L.
Afonso, Carlos
Tiritan, Maria E.
author_role author
author2 Castro, Paula M.L.
Afonso, Carlos
Tiritan, Maria E.
author2_role author
author
author
dc.contributor.none.fl_str_mv Veritati
dc.contributor.author.fl_str_mv Ribeiro, Ana R.
Castro, Paula M.L.
Afonso, Carlos
Tiritan, Maria E.
dc.subject.por.fl_str_mv biodegradation
chiral
pharmaceuticals
topic biodegradation
chiral
pharmaceuticals
description Chiral pharmaceuticals and the fate and effects of their enantiomers in the environment are still largely unknown [1, 2]. Enantiomers have different interactions with enzymes, receptors and any chiral molecules leading to different biological activities and affecting organisms in a different manner. Thus, biodegradation tends to be enantioselective in contrast to abiotic degradation. The methods developed to quantify the enantiomeric fraction in the environment and to follow biodegradation are scarce [3]. Thus in this work we describe the development and validation of HPLC methods that allow the enantiomeric separation of widely used drugs namely four beta-blockers: alprenolol (ALP), propranolol (PHO), metoprolol (MET) and atenolol (ATE) and the antidepressant fluoxetine (FX). The macrocyclic antibiotic vancomycin CSP (ASTEC Chirobiotic V 5µm) was used under polar organic mode (methanol:ethanol:triethylamine:acetic acid.50:50 v/v) and fluorescence detection for enantiomeric fraction quantification. The developed methods were established using a minimal medium inoculated with activated sludge as a matrix which is the condition used in the biodegradation studies. The vancomycin CSP was able to resolve ALP and PHO as well as MET, ATE and FX in two chromatographic runs. The chromatographic parameters obtained have shown the separation factor (α) between 1.12 and 1.34 and resolution (Rs) between 1.30 and 4.35. The methods demonstrated to be selective and linearity with r2 higher than 0,999 for the range selected. The method detection limits were between 2.5 to 10ng/mL. These methods were applied to follow the biodegradation of the target chiral compounds during 15 days. The biodegradation assays were performed using activated sludge from a WWTP and the results indicate the higher degradation extents for the S- enantiomer forms.
publishDate 2011
dc.date.none.fl_str_mv 2011
2011-01-01T00:00:00Z
2013-11-14T16:20:17Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/13239
url http://hdl.handle.net/10400.14/13239
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833601330573213696